Skip to main content
PMC home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1954 Apr;30(4):239–277.

Basic Mechanisms of Hemostasis*

Mario Stefanini
PMCID: PMC1804474  PMID: 13141058

Full text

PDF
239

Images in this article

246Figure 4
on p.246
242Figure 2
on p.242
268Figure 17
on p.268

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B., GOLDSTEIN R., LANDWEHR G. The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation. J Clin Invest. 1951 Mar;30(3):252–262. doi: 10.1172/JCI102439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALEXANDER B., GOLDSTEIN R. Parahemophilia in three siblings (Owren's disease). Am J Med. 1952 Sep;13(3):255–272. doi: 10.1016/0002-9343(52)90281-7. [DOI] [PubMed] [Google Scholar]
  3. BIGGS R., DOUGLAS A. S., MACFARLANE R. G., DACIE J. V., PITNEY W. R., MERSKEY Christmas disease: a condition previously mistaken for haemophilia. Br Med J. 1952 Dec 27;2(4799):1378–1382. doi: 10.1136/bmj.2.4799.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CAMPBELL E. W., STEFANINI M. Isolation and purification of plasma thromboplastin: its physico-chemical and biologic properties. Proc Soc Exp Biol Med. 1953 May;83(1):105–110. doi: 10.3181/00379727-83-20279. [DOI] [PubMed] [Google Scholar]
  5. DE ROBERTIS E., PASEYRO P., REISSIG M. Electron microscopic studies of the action of thrombin on blood platelets. Blood. 1953 Jul;8(7):587–597. [PubMed] [Google Scholar]
  6. DUCKERT F., KOLLER F., MATTER M. Purification and physiological properties of factor VII from plasma and serum; separation from prothrombin. Proc Soc Exp Biol Med. 1953 Feb;82(2):259–261. doi: 10.3181/00379727-82-20084. [DOI] [PubMed] [Google Scholar]
  7. KOLLER F., LOELIGER A., DUCKERT F. Experiments on a new clotting factor (factor VII). Acta Haematol. 1951;6(1):1–18. doi: 10.1159/000203899. [DOI] [PubMed] [Google Scholar]
  8. LEWIS J. H., FERGUSON J. H. Partial purification of human prothrombin and proconvertin: their characteristics and interaction. J Clin Invest. 1953 Oct;32(10):915–921. doi: 10.1172/JCI102816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lewis J. H., Ferguson J. H. THROMBIN FORMATION. I. THE ROLE OF CALCIUM, SERUM AC-GLOBULIN AND TISSUE THROMBOPLASTIN. J Clin Invest. 1948 Nov;27(6):778–784. doi: 10.1172/JCI102028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MILSTONE J. H. The chain reaction of the blood clotting mechanism in relation to the theory of hemostasis and thrombosis. Blood. 1949 Dec;4(12):1290–1297. [PubMed] [Google Scholar]
  11. MINOR A. H., BURNETT L. A method for separating and concentrating platelets from normal human blood. Blood. 1952 Jul;7(7):693–699. [PubMed] [Google Scholar]
  12. MORRISON P. R., SCUDDER C. L. Fibrin clot structure during clotting as observed in unsupported films under electron microscope. Am J Physiol. 1952 Jul;170(1):147–154. doi: 10.1152/ajplegacy.1952.170.1.147. [DOI] [PubMed] [Google Scholar]
  13. ORBISON J. L. Morphology of thrombotic thrombocytopenic purpura with demonstration of aneurysms. Am J Pathol. 1952 Jan-Feb;28(1):129–143. [PMC free article] [PubMed] [Google Scholar]
  14. OWREN P. A. La proconvertine. Rev Hematol. 1952;7(2):147–155. [PubMed] [Google Scholar]
  15. RATNOFF O. D. Studies on a proteolytic enzyme in human plasma. VII. A fatal hemorrhagic state associated with excessive plasma proteolytic activity in a patient undergoing surgery for carcinoma of the head of the pancreas. J Clin Invest. 1952 May;31(5):521–528. doi: 10.1172/JCI102636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. ROBSON H. N., DUTHIE J. J. R. Capillary resistance and adrenocortical activity. Br Med J. 1950 Oct 28;2(4686):971–977. doi: 10.1136/bmj.2.4686.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. ROSENTHAL R. L., DRESKIN O. H., ROSENTHAL N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953 Jan;82(1):171–174. doi: 10.3181/00379727-82-20057. [DOI] [PubMed] [Google Scholar]
  18. SCHULMAN I., SMITH C. H. Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood. 1952 Aug;7(8):794–807. [PubMed] [Google Scholar]
  19. SEEGERS W. H. A new plasma antithrombin reaction. Arch Biochem Biophys. 1952 Apr;36(2):484–484. doi: 10.1016/0003-9861(52)90437-2. [DOI] [PubMed] [Google Scholar]
  20. SEEGERS W. H., McCLAUGHRY R. I., FAHEY J. L. Some properties of purified prothrombin and its activation with sodium citrate. Blood. 1950 May;5(5):421–433. [PubMed] [Google Scholar]
  21. SHINOWARA G. Y. Enzyme studies on human blood. XI. The isolation and characterization of thromboplastic cell and plasma components. J Lab Clin Med. 1951 Jul;38(1):11–22. [PubMed] [Google Scholar]
  22. STEFANINI M. Autocatalytic formation of thrombin in blood coagulation. Acta Med Scand. 1951;140(4):290–306. doi: 10.1111/j.0954-6820.1951.tb10180.x. [DOI] [PubMed] [Google Scholar]
  23. STEFANINI M., CHATTERJEA J. B. Studies on platelets. IV. A thrombocytopenic factor in normal human blood, plasma, or serum. Proc Soc Exp Biol Med. 1952 Apr;79(4):623–629. doi: 10.3181/00379727-79-19466. [DOI] [PubMed] [Google Scholar]
  24. STEFANINI M., CROSBY W. H. Utilization of the labile factor during normal and abnormal coagulation of blood. Proc Soc Exp Biol Med. 1950 Jun;74(2):370–372. doi: 10.3181/00379727-74-17911. [DOI] [PubMed] [Google Scholar]
  25. STEFANINI M., DAMESHEK W. Collection, preservation and transfusion of platelets; with special reference to the factors affecting the survival rate and the clinical effectiveness of transfused platelets. N Engl J Med. 1953 May 7;248(19):797–802. doi: 10.1056/NEJM195305072481901. [DOI] [PubMed] [Google Scholar]
  26. STEFANINI M. Seminars on blood coagulation; mechanism of blood coagulation in normal and pathologic conditions. Am J Med. 1953 Jan;14(1):64–86. doi: 10.1016/0002-9343(53)90359-3. [DOI] [PubMed] [Google Scholar]
  27. TAGNON H. J., WHITMORE W. F., Jr, SHULMAN N. R. Fibrinolysis in metastatic cancer of the prostate. Cancer. 1952 Jan;5(1):9–12. doi: 10.1002/1097-0142(195201)5:1<9::aid-cncr2820050104>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  28. UNGAR G., DAMGAARD E. Studies on the fibrinolysin-antifibrinolysin system in serum. I. Action of the anterior pituitary, adrenal cortex, and spleen. J Exp Med. 1951 Jan;93(1):89–97. doi: 10.1084/jem.93.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WALDENSTROM J. Three new cases of purpura hyperglobulinemica. A study in long-lasting benign increase in serum globulin. Acta Med Scand Suppl. 1952;266:931–946. [PubMed] [Google Scholar]
  30. WHITE S. G., AGGELER P. M., GLENDENING M. B. Plasma thromboplastin component (PTC), a hitherto unrecognized blood coagulation factor; case report of PTC deficiency. Blood. 1953 Feb;8(2):101–124. [PubMed] [Google Scholar]
  31. van CREVOLD S., PAULSSEN M. M. P. Significance of clotting factors in blood-platelets, in normal and pathological conditions. Lancet. 1951 Aug 11;2(6676):242–244. [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES